{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:58:59Z","timestamp":1791410339713,"version":"4.3.3"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CJD Support Network UK"},{"name":"NIHR Biomedical Research Centre at University College London Hospitals NHS Foundation Trust"},{"DOI":"10.13039\/501100000320","name":"Alzheimer's Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The cerebrospinal fluid (CSF) real-time quaking-induced conversion assay (RT-QuIC) is an ultrasensitive prion amyloid seeding assay for diagnosis of sporadic Creutzfeldt\u2013Jakob disease (CJD) but several prion strains remain unexplored or resistant to conversion with commonly used recombinant prion protein (rPrP) substrates. Here, bank vole (BV) rPrP was used to study seeding by a wide range of archived post-mortem human CSF samples from cases of sporadic, acquired and various inherited prion diseases in high throughput 384-well format. BV rPrP substrate yielded positive reactions in 70\/79 cases of sporadic CJD [Sensitivity 88.6% (95% CI 79.5\u201394.7%)], 1\/2 variant CJD samples, and 9\/20 samples from various inherited prion diseases; 5\/57 non-prion disease control CSFs had positive reactions, yielding an overall specificity of 91.2% (95% CI 80.1\u201397.1%). Despite limitations of using post-mortem samples and our results\u2019 discrepancy with other studies, we demonstrated for the first time that BV rPrP is susceptible to conversion by human CSF samples containing certain prion strains not previously responsive in conventional rPrPs, thus justifying further optimisation for wider diagnostic and prognostic use.<\/jats:p>","DOI":"10.1038\/s41598-021-84527-9","type":"journal-article","created":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T11:04:29Z","timestamp":1614855869000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Bank vole prion protein extends the use of RT-QuIC assays to detect prions in a range of inherited prion diseases"],"prefix":"10.1038","volume":"11","author":[{"given":"Tze How","family":"Mok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akin","family":"Nihat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie","family":"Luk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Sequeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Batchelor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Mead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Collinge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham S.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,4]]},"reference":[{"key":"84527_CR1","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1146\/annurev.neuro.24.1.519","volume":"24","author":"J Collinge","year":"2001","unstructured":"Collinge, J. Prion diseases of humans and animals: Their causes and molecular basis. Annu. Rev. Neurosci. 24, 519\u2013550 (2001).","journal-title":"Annu. Rev. Neurosci."},{"key":"84527_CR2","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","volume":"46","author":"P Parchi","year":"1999","unstructured":"Parchi, P. et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann. Neurol. 46, 224\u2013233 (1999).","journal-title":"Ann. Neurol."},{"key":"84527_CR3","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/383685a0","volume":"383","author":"J Collinge","year":"1996","unstructured":"Collinge, J., Sidle, K. C. L., Meads, J., Ironside, J. & Hill, A. F. Molecular analysis of prion strain variation and the aetiology of \u2018new variant\u2019 CJD. Nature 383, 685\u2013690 (1996).","journal-title":"Nature"},{"key":"84527_CR4","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/brain\/awl013","volume":"129","author":"AF Hill","year":"2006","unstructured":"Hill, A. F. et al. Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations. Brain J. Neurol. 129, 676\u2013685 (2006).","journal-title":"Brain J. Neurol."},{"key":"84527_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/978-1-59745-234-2_14","volume":"459","author":"JDF Wadsworth","year":"2008","unstructured":"Wadsworth, J. D. F. et al. Molecular diagnosis of human prion disease. Methods Mol. Biol. Clifton 459, 197\u2013227 (2008).","journal-title":"Methods Mol. Biol. Clifton"},{"key":"84527_CR6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/sj.ejhg.5201544","volume":"14","author":"S Mead","year":"2006","unstructured":"Mead, S. Prion disease genetics. Eur. J. Hum. Genet. EJHG 14, 273\u2013281 (2006).","journal-title":"Eur. J. Hum. Genet. EJHG"},{"key":"84527_CR7","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrneurol.2014.263","volume":"11","author":"S Mead","year":"2015","unstructured":"Mead, S. & Reilly, M. M. A new prion disease: relationship with central and peripheral amyloidoses. Nat. Rev. Neurol. 11, 90\u201397 (2015).","journal-title":"Nat. Rev. Neurol."},{"key":"84527_CR8","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1056\/NEJMoa1214747","volume":"369","author":"S Mead","year":"2013","unstructured":"Mead, S. et al. A novel prion disease associated with diarrhea and autonomic neuropathy. N. Engl. J. Med. 369, 1904\u20131914 (2013).","journal-title":"N. Engl. J. Med."},{"key":"84527_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2018.12.003","author":"AGB Thompson","year":"2018","unstructured":"Thompson, A. G. B. & Mead, S. H. Review: Fluid biomarkers in the human prion diseases. Mol. Cell. Neurosci. https:\/\/doi.org\/10.1016\/j.mcn.2018.12.003 (2018).","journal-title":"Mol. Cell. Neurosci."},{"key":"84527_CR10","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1056\/NEJM199609263351303","volume":"335","author":"G Hsich","year":"1996","unstructured":"Hsich, G., Kenney, K., Gibbs, C. J., Lee, K. H. & Harrington, M. G. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N. Engl. J. Med. 335, 924\u2013930 (1996).","journal-title":"N. Engl. J. Med."},{"key":"84527_CR11","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1212\/WNL.0b013e31826d5fc3","volume":"79","author":"T Muayqil","year":"2012","unstructured":"Muayqil, T., Gronseth, G. & Camicioli, R. Evidence-based guideline: Diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: Report of the guideline development subcommittee of the American Academy of Neurology. Neurology 79, 1499\u20131506 (2012).","journal-title":"Neurology"},{"key":"84527_CR12","unstructured":"Diagnosis and Testing|CJD. https:\/\/www.cjd.ed.ac.uk\/surveillance\/diagnosis-and-testing."},{"key":"84527_CR13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nm.2294","volume":"17","author":"R Atarashi","year":"2011","unstructured":"Atarashi, R. et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat. Med. 17, 175\u2013178 (2011).","journal-title":"Nat. Med."},{"key":"84527_CR14","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/ana.23589","volume":"72","author":"LI McGuire","year":"2012","unstructured":"McGuire, L. I. et al. Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease. Ann. Neurol. 72, 278\u2013285 (2012).","journal-title":"Ann. Neurol."},{"key":"84527_CR15","doi-asserted-by":"publisher","first-page":"e1004983","DOI":"10.1371\/journal.ppat.1004983","volume":"11","author":"CD Orr\u00fa","year":"2015","unstructured":"Orr\u00fa, C. D. et al. Bank vole prion protein as an apparently universal substrate for RT-QuIC-based detection and discrimination of prion strains. PLoS Pathog. 11, e1004983 (2015).","journal-title":"PLoS Pathog."},{"key":"84527_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mBio.02451-14","volume":"6","author":"CD Orr\u00fa","year":"2015","unstructured":"Orr\u00fa, C. D. et al. Rapid and sensitive RT-QuIC detection of human Creutzfeldt-Jakob disease using cerebrospinal fluid. mBio 6, 1 (2015).","journal-title":"mBio"},{"key":"84527_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.aam7785","volume":"9","author":"CD Orr\u00fa","year":"2017","unstructured":"Orr\u00fa, C. D. et al. Prion seeding activity and infectivity in skin samples from patients with sporadic Creutzfeldt-Jakob disease. Sci. Transl. Med. 9, 1 (2017).","journal-title":"Sci. Transl. Med."},{"key":"84527_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1001\/jamaneurol.2016.4614","volume":"74","author":"M Bongianni","year":"2017","unstructured":"Bongianni, M. et al. Diagnosis of human prion disease using real-time quaking-induced conversion testing of olfactory mucosa and cerebrospinal fluid samples. JAMA Neurol. 74, 155\u2013162 (2017).","journal-title":"JAMA Neurol."},{"key":"84527_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3390\/v8050140","volume":"8","author":"CD Orr\u00fa","year":"2016","unstructured":"Orr\u00fa, C. D. et al. Factors that improve RT-QuIC detection of prion seeding activity. Viruses 8, 140 (2016).","journal-title":"Viruses"},{"key":"84527_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/acn3.378","volume":"4","author":"BR Groveman","year":"2017","unstructured":"Groveman, B. R. et al. Extended and direct evaluation of RT-QuIC assays for Creutzfeldt-Jakob disease diagnosis. Ann. Clin. Transl. Neurol. 4, 139\u2013144 (2017).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"84527_CR21","doi-asserted-by":"publisher","first-page":"10655","DOI":"10.1038\/s41598-017-10922-w","volume":"7","author":"A Franceschini","year":"2017","unstructured":"Franceschini, A. et al. High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions. Sci. Rep. 7, 10655 (2017).","journal-title":"Sci. Rep."},{"key":"84527_CR22","doi-asserted-by":"publisher","first-page":"e54915","DOI":"10.1371\/journal.pone.0054915","volume":"8","author":"K Sano","year":"2013","unstructured":"Sano, K. et al. Early detection of abnormal prion protein in genetic human prion diseases now possible using real-time QUIC assay. PLoS ONE 8, e54915 (2013).","journal-title":"PLoS ONE"},{"key":"84527_CR23","doi-asserted-by":"publisher","first-page":"e1004953","DOI":"10.1371\/journal.ppat.1004953","volume":"11","author":"EA Asante","year":"2015","unstructured":"Asante, E. A. et al. Transmission properties of human PrP 102L prions challenge the relevance of mouse models of GSS. PLoS Pathog. 11, e1004953 (2015).","journal-title":"PLoS Pathog."},{"key":"84527_CR24","doi-asserted-by":"publisher","first-page":"e1003643","DOI":"10.1371\/journal.ppat.1003643","volume":"9","author":"EA Asante","year":"2013","unstructured":"Asante, E. A. et al. Inherited prion disease A117V is not simply a proteinopathy but produces prions transmissible to transgenic mice expressing homologous prion protein. PLoS Pathog. 9, e1003643 (2013).","journal-title":"PLoS Pathog."},{"key":"84527_CR25","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1371\/journal.ppat.0020012","volume":"2","author":"R Nonno","year":"2006","unstructured":"Nonno, R. et al. Efficient transmission and characterization of Creutzfeldt-Jakob disease strains in bank voles. PLoS Pathog. 2, e12 (2006).","journal-title":"PLoS Pathog."},{"key":"84527_CR26","doi-asserted-by":"publisher","first-page":"e1003990","DOI":"10.1371\/journal.ppat.1003990","volume":"10","author":"JC Watts","year":"2014","unstructured":"Watts, J. C. et al. Evidence that bank vole PrP is a universal acceptor for prions. PLoS Pathog. 10, e1003990 (2014).","journal-title":"PLoS Pathog."},{"key":"84527_CR27","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1093\/brain\/awt048","volume":"136","author":"AGB Thompson","year":"2013","unstructured":"Thompson, A. G. B. et al. The Medical Research Council prion disease rating scale: a new outcome measure for prion disease therapeutic trials developed and validated using systematic observational studies. Brain J. Neurol. 136, 1116\u20131127 (2013).","journal-title":"Brain J. Neurol."},{"key":"84527_CR28","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1001\/jamaneurol.2015.4885","volume":"73","author":"S Mead","year":"2016","unstructured":"Mead, S. et al. Clinical trial simulations based on genetic stratification and the natural history of a functional outcome measure in Creutzfeldt-Jakob disease. JAMA Neurol. 73, 447 (2016).","journal-title":"JAMA Neurol."},{"key":"84527_CR29","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/2051-5960-1-44","volume":"1","author":"S Shi","year":"2013","unstructured":"Shi, S., Mitteregger-Kretzschmar, G., Giese, A. & Kretzschmar, H. A. Establishing quantitative real-time quaking-induced conversion (qRT-QuIC) for highly sensitive detection and quantification of PrPSc in prion-infected tissues. Acta Neuropathol. Commun. 1, 44 (2013).","journal-title":"Acta Neuropathol. Commun."},{"issue":"46","key":"84527_CR30","doi-asserted-by":"publisher","first-page":"23029","DOI":"10.1073\/pnas.1909322116","volume":"116","author":"MA Metrick","year":"2019","unstructured":"Metrick, M. A. et al. Million-fold sensitivity enhancement in proteopathic seed amplification assays for biospecimens by Hofmeister ion comparisons. Proc. Natl. Acad. Sci. 116(46), 23029\u201323039 (2019).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"84527_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/ana.24833","volume":"81","author":"A Foutz","year":"2017","unstructured":"Foutz, A. et al. Diagnostic and prognostic value of human prion detection in cerebrospinal fluid. Ann. Neurol. 81, 79\u201392 (2017).","journal-title":"Ann. Neurol."},{"key":"84527_CR32","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s12035-014-8709-6","volume":"51","author":"M Cramm","year":"2015","unstructured":"Cramm, M. et al. Characteristic CSF prion seeding efficiency in humans with prion diseases. Mol. Neurobiol. 51, 396\u2013405 (2015).","journal-title":"Mol. Neurobiol."},{"key":"84527_CR33","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12916-020-01608-8","volume":"18","author":"SM Vallabh","year":"2020","unstructured":"Vallabh, S. M. et al. Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease. BMC Med. 18, 140 (2020).","journal-title":"BMC Med."},{"key":"84527_CR34","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1007\/s12035-015-9133-2","volume":"53","author":"M Cramm","year":"2016","unstructured":"Cramm, M. et al. Stability and reproducibility underscore utility of RT-QuIC for diagnosis of Creutzfeldt-Jakob disease. Mol. Neurobiol. 53, 1896\u20131904 (2016).","journal-title":"Mol. Neurobiol."},{"key":"84527_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1136\/practneurol-2018-001935","volume":"19","author":"AJE Green","year":"2019","unstructured":"Green, A. J. E. RT-QuIC: A new test for sporadic CJD. Pract. Neurol. 19, 49\u201355 (2019).","journal-title":"Pract. Neurol."},{"key":"84527_CR36","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1080\/10408363.2019.1619158","volume":"56","author":"P-A Peyron","year":"2019","unstructured":"Peyron, P.-A., Lehmann, S., Delaby, C., Baccino, E. & Hirtz, C. Biochemical markers of time since death in cerebrospinal fluid: A first step towards \u201cForensomics\u201d. Crit. Rev. Clin. Lab. Sci. 56, 274\u2013286 (2019).","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"84527_CR37","doi-asserted-by":"publisher","first-page":"20914","DOI":"10.1073\/pnas.0710152105","volume":"104","author":"DW Colby","year":"2007","unstructured":"Colby, D. W. et al. Prion detection by an amyloid seeding assay. Proc. Natl. Acad. Sci. 104, 20914\u201320919 (2007).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"84527_CR38","doi-asserted-by":"publisher","first-page":"e1001217","DOI":"10.1371\/journal.ppat.1001217","volume":"6","author":"JM Wilham","year":"2010","unstructured":"Wilham, J. M. et al. Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays. PLoS Pathog. 6, e1001217 (2010).","journal-title":"PLoS Pathog."},{"key":"84527_CR39","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.1073\/pnas.110523897","volume":"97","author":"M Horiuchi","year":"2000","unstructured":"Horiuchi, M., Priola, S. A., Chabry, J. & Caughey, B. Interactions between heterologous forms of prion protein: Binding, inhibition of conversion, and species barriers. Proc. Natl. Acad. Sci. USA. 97, 5836\u20135841 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"84527_CR40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0379-0738(83)90007-5","volume":"22","author":"P Mangin","year":"1983","unstructured":"Mangin, P., Lugnier, A.-A., Chaumont, A.-J., Offner, M. & Grucker, M. Forensic significance of postmortem estimation of the blood cerebrospinal fluid barrier permeability. Forensic Sci. Int. 22, 143\u2013149 (1983).","journal-title":"Forensic Sci. Int."},{"key":"84527_CR41","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0379-0738(92)90107-8","volume":"52","author":"E Osuna","year":"1992","unstructured":"Osuna, E., Perez-Carceles, M. D., Luna, A. & Pounder, D. J. Efficacy of cerebro-spinal fluid biochemistry in the diagnosis of brain insult. Forensic Sci. Int. 52, 193\u2013198 (1992).","journal-title":"Forensic Sci. Int."},{"key":"84527_CR42","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/BF01371336","volume":"106","author":"D Wyler","year":"1994","unstructured":"Wyler, D., Marty, W. & Bir, W. Correlation between the post-mortem cell content of cerebrospinal fluid and time of death. Int. J. Legal Med. 106, 194\u2013199 (1994).","journal-title":"Int. J. Legal Med."},{"key":"84527_CR43","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1126\/science.1138718","volume":"318","author":"J Collinge","year":"2007","unstructured":"Collinge, J. & Clarke, A. R. A general model of prion strains and their pathogenicity. Science 318, 930\u2013936 (2007).","journal-title":"Science"},{"key":"84527_CR44","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nature09768","volume":"470","author":"MK Sandberg","year":"2011","unstructured":"Sandberg, M. K., Al-Doujaily, H., Sharps, B., Clarke, A. R. & Collinge, J. Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature 470, 540\u2013542 (2011).","journal-title":"Nature"},{"key":"84527_CR45","doi-asserted-by":"publisher","first-page":"4347","DOI":"10.1038\/ncomms5347","volume":"5","author":"MK Sandberg","year":"2014","unstructured":"Sandberg, M. K. et al. Prion neuropathology follows the accumulation of alternate prion protein isoforms after infective titre has peaked. Nat. Commun. 5, 4347 (2014).","journal-title":"Nat. Commun."},{"key":"84527_CR46","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/S1474-4422(09)70049-3","volume":"8","author":"J Collinge","year":"2009","unstructured":"Collinge, J. et al. Safety and efficacy of quinacrine in human prion disease (PRION-1 study): A patient-preference trial. Lancet Neurol. 8, 334\u2013344 (2009).","journal-title":"Lancet Neurol."},{"key":"84527_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0167-4838(99)00038-2","volume":"1431","author":"GS Jackson","year":"1999","unstructured":"Jackson, G. S. et al. Multiple folding pathways for heterologously expressed human prion protein. Biochim. Biophys. Acta BBA 1431, 1\u201313 (1999).","journal-title":"Biochim. Biophys. Acta BBA"},{"key":"84527_CR48","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1093\/brain\/awg125","volume":"126","author":"AF Hill","year":"2003","unstructured":"Hill, A. F. et al. Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain J. Neurol. 126, 1333\u20131346 (2003).","journal-title":"Brain J. Neurol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84527-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84527-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84527-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T04:57:42Z","timestamp":1670043462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84527-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,4]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["84527"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-84527-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,4]]},"assertion":[{"value":"10 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5231"}}